Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2023-12-25 幸运非偶然来自陕西省

偏重的研究方向：肿瘤学
经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静

33 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2024-01-29 ms3000000325522353 来自江苏省

请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2023-08-29 LCXXXX 来自黑龙江省

偏重的研究方向：生物信息学
经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑

1 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2024-02-15 幸运非偶然来自陕西省

求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2024-02-16 ms6000001790334235 来自重庆

well

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2024-02-14 ms6000001790334235 来自重庆

well

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2023-12-01 ms9000001842036470 来自辽宁省

目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里

56 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2023-12-26 jianghualiu0107 来自广西

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：ARDS
经验分享：11月15日提交
11月15格式修改再投
11月25日通过技术检查
11月25日under peer review
12月14日2 Reviewers accepted
12月到现在 waiting Reviewer report

37 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2024-01-09 ms9000001314913623 来自山西省

审稿速度:12.0 | 投稿命中率:50.0
经验分享：Editors invited 20天了……

35 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176984, encodeId=e4c621e69842c, content=偏重的研究方向：肿瘤学 经验分享：1 Reviewer report received 31 Oct 23 两个月了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Mon Dec 25 09:15:20 CST 2023, time=2023-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2184683, encodeId=a78621846837f, content=请问 reviewer reports received/Ready for editor‘s decision是什么状态，审稿意见是发给通讯作者还是第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aee8605680, createdName=ms3000000325522353, createdTime=Mon Jan 29 18:23:36 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2155163, encodeId=1290215516332, content=偏重的研究方向：生物信息学 经验分享：请问大家，7月1日投的，8月23号开始邀请审稿人了，8月24号显示已经有8个审稿人接受邀请了，但是过去快一周了，一个意见都没有返回来，还要等多少才能确定下来？是不是即使8个审稿人接受邀请，最后真的进行评审的也没几个？很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Tue Aug 29 19:01:30 CST 2023, time=2023-08-29, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2187413, encodeId=7908218e41307, content=求助，修回后状态从Submission passed technical check变成editor evaluation revision又变成Technical check passed了，时间没变，是什么意思啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/05/31/72a1c129ce15ee5d5763c2f384f96c8e.jpeg, createdBy=ab221959608, createdName=幸运非偶然, createdTime=Thu Feb 15 15:17:51 CST 2024, time=2024-02-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2187546, encodeId=c4b6218e5466e, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Fri Feb 16 08:54:06 CST 2024, time=2024-02-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2187281, encodeId=4f0d218e2810d, content=well, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Wed Feb 14 13:09:18 CST 2024, time=2024-02-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172381, encodeId=246321e2381d4, content=目前，Scientific Reports的技术审查多久啊，已经快半个月了，一直卡在技术审查那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf719083791, createdName=ms9000001842036470, createdTime=Fri Dec 01 18:48:05 CST 2023, time=2023-12-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2177249, encodeId=722d21e724901, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：ARDS 经验分享：11月15日提交 11月15格式修改再投 11月25日通过技术检查 11月25日under peer review 12月14日2 Reviewers accepted 12月到现在 waiting Reviewer report, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8DSVEvF5IS4IfYq1UFXZaf2MGsFyjMdkh4h8c5Wjcgkkpib1iadptcJnENjEXUuYSbea3iaFwIEuaMD6yKUJIia2ew/132, createdBy=54702535148, createdName=jianghualiu0107, createdTime=Tue Dec 26 12:45:44 CST 2023, time=2023-12-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2180379, encodeId=dbed21803e90c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Editors invited 20天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22a49088917, createdName=ms9000001314913623, createdTime=Tue Jan 09 22:23:43 CST 2024, time=2024-01-09, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2166199, encodeId=4e0021661994a, content=偏重的研究方向：肿瘤;临床 经验分享：20 Reviewer(s) invited 24 Oct 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Nov 01 22:10:18 CST 2023, time=2023-11-01, status=1, ipAttribution=广西)]

2023-11-01 水逆退散～来自广西

偏重的研究方向：肿瘤;临床
经验分享：20 Reviewer(s) invited 24 Oct 23

75 18

展开18条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务